Navigation Links
Dyadic International Enters Into Research and License Agreement With Major Player in the Animal Feed Industry
Date:6/27/2011

JUPITER, Fla., June 27, 2011 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the industrial enzyme, bioenergy, and biopharmaceutical industries, announced today that it has entered into a long-term research, development and license agreement with a key provider of animal nutritional solutions throughout the world (the "Commercial Partner"), to develop, manufacture and commercialize animal feed enzyme products.

(Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO)

Under the agreement, the Commercial Partner will continue its successful research cooperation with Dyadic's R&D subsidiary, Dyadic Netherlands, and utilize Dyadic's patented and proprietary C1 platform technology to develop fungal strains that will produce high levels of enzymes for feed applications.

As part of this agreement, Dyadic has granted the Commercial Partner a worldwide license to use the developed C1 fungal strains to manufacture and sell animal feed enzyme products. Dyadic will receive an upfront access fee and be eligible to receive a commercial milestone payment as well as royalties based on the Commercial Partner's worldwide sales of products which utilize the C1 technology platform.

In accordance with Dyadic's confidentiality obligations under the agreement, no additional information on the identity of the Commercial Partner or the terms of the agreement can be disclosed.

Dyadic's President and Chief Executive Officer, Mark Emalfarb, stated, "We are very fortunate to partner with a global player in the animal feed industry to grow our respective businesses in one of the largest and fastest growing enzyme markets. Through our growing relationship with this party, Dyadic has demonstrated and expects to continue to show the benefits of using Dyadic's C1 technology for the development of novel
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dyadic International Extends Collaboration With The Scripps Research Institute
2. Dyadic International Strengthens Management Team
3. Dyadic International to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference
4. Dyadic International Engages The Abraham Group as Strategic Advisor
5. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
6. Dyadic International to Announce Second Quarter 2010 Financial Results and Hold Conference Call on August 13, 2010
7. Dyadic International Raises $3 Million in Private Placement of Convertible Notes
8. Dyadic International to Announce Third Quarter 2010 Financial Results and Hold Conference Call on November 15, 2010
9. Dyadic International Reports 2010 Third Quarter Financial Results
10. Dyadic International Launches High Performance Enzyme for Pulp and Paper Industry Using New C1 Production Platform
11. Dyadic International Reports 2010 Fiscal Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... CORAL SPRINGS, Florida , September 19, 2014 /PRNewswire/ ... biotech companies release latest developments, patents and results of ... (OTC: GNSZ), Eli Lilly and Company (NYSE: ... ), Celgene Corporation (NASDAQ: CELG ) and ... (OTCQB: GNSZ), a leader in developing prodrug therapeutics for ...
(Date:9/19/2014)... 2014 , The first grants ... Paediatric Endocrinology (ESPE) Meeting  Investment supports innovative ... in the field of growth  , EMD ... Germany , today announced the first recipients of ... awards were announced during a Satellite Symposium organized by ...
(Date:9/18/2014)... About POCT POCT, ... clinical laboratory. It helps in making fast clinical ... medication. POCT is gaining popularity due to the ... as diabetes, heart disease, and obesity. It is ... to minimize errors during the diagnosis of patients. ...
(Date:9/18/2014)... , September 18, 2014 ... ( http://www.researchandmarkets.com/research/czvg3s/biocompatible ) has announced the ... - Global Strategic Business Report" ... http://photos.prnewswire.com/prnh/20130307/600769) ,This report analyzes the worldwide ... Million by the following Product Segments: ...
Breaking Biology Technology:Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3POCT Market in China 2014-2018 2Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3
... a positive third,quarter, the biotech industry continued its upward climb ... the state of the economy,and interest rate jitters as the ... Index, for example, rose an impressive 6.1% in,October -- in ... ahead of the,DJIA which was unchanged. "Entering the final ...
... COLUMBIA, Md., Nov. 1 Martek Biosciences,Corporation (Nasdaq: ... in the United,States District Court in Wilmington, Delaware, ... a permanent injunction in Martek,s favor,against the defendants ... Lonza, Ltd., Nutrinova Inc. and Nutrinova Nutrition Specialties ...
... provide free home caregiving to disabled veterans, ... its,2007 We Care For Veterans campaign to honor ... qualified disabled veterans. (Logo: http://www.newscom.com/cgi-bin/prnh/20070521/LAM004ALOGO ) ... are,donating 20 hours each of free in-home care ...
Cached Biology Technology:Biotech Continues Upward Climb in October 2Biotech Continues Upward Climb in October 3Biotech Continues Upward Climb in October 4Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge 2Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge 3Homewatch CareGivers Launches 2007 We Care For Veterans Campaign 2
(Date:9/21/2014)... working at the University of California, San Diego, have ... marks that control the activity of genes based on ... results from its application to human embryonic cells in ... September 21. , "All of our cells have the ... functions," said John Whitaker, lead author of the report. ...
(Date:9/19/2014)... Call it the Jimmy Durante of dinosaurs ... nasal profile. The new dinosaur, named Rhinorex ... University and Brigham Young University, lived in what ... during the Late Cretaceous period. , Rhinorex, which ... and a close relative of other Cretaceous hadrosaurs ...
(Date:9/19/2014)... species which over thousands of years has adapted to the ... that makes the cold dangerous for you. , This is ... and the cold provoking substance, called nonylphenol, comes from the ... suspected of being a endocrine disruptor, but when entering the ... ability to protect the cells in its body from cold ...
Breaking Biology News(10 mins):Program predicts placement of chemical tags that control gene activity 2New hadrosaur noses into spotlight 2Environmental pollutants make worms susceptible to cold 2Environmental pollutants make worms susceptible to cold 3
... Researchers have been unable to build an ideal photonic ... ultrafast optical computers. But now, University of Utah chemists ... with the ideal, diamond-like structure: They are found in ... Brazil. It appears that a simple creature like ...
... of the greatest zoological mysteries for over a century. ... puzzling crustaceans, despite the plethora of these larvae in ... what y- larvae grow up to be. A study ... reports the transformation of the larvae into a previously ...
... the Great Lakes have prompted the need to better ... collaborative project is aimed at improving information for beach ... close beaches to protect public health. This collaborative effort ... and other federal, state and local agencies. ...
Cached Biology News:The photonic beetle 2The photonic beetle 3The photonic beetle 4The photonic beetle 5Clue to mystery crustacean in parasite form 2To swim or not to swim? 2
... intensely fluorescent and highly photostable FluoSpheres ... in a variety of applications requiring ... signal. Unfortunately, protein- and other macromolecule-labeled ... cause them to bind to non-target ...
Goat polyclonal to Duffy / FY / DARC...
SMVT (N-14)...
... Source: Tritirachium album Description: ... endopeptidase used in a wide range of applications ... peptide bonds mainly following the carboxyl group of ... and is classified as a serine protease. ...
Biology Products: